sorafenib has been researched along with Myofibromatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt, C; Bidadi, B; Kirkham, J; Oliveira, A; Watson, A; Weigel, B | 1 |
1 other study(ies) available for sorafenib and Myofibromatosis
| Article | Year |
|---|---|
Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imatinib Mesylate; Infant; Myofibromatosis; Prognosis; Sorafenib | 2020 |